230 related articles for article (PubMed ID: 22973955)
21. Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies.
Caiazza F; Elliott L; Fennelly D; Sheahan K; Doherty GA; Ryan EJ
Biomark Med; 2015; 9(4):363-75. PubMed ID: 25808440
[TBL] [Abstract][Full Text] [Related]
22. Targeted therapy in advanced colorectal cancer: more data, more questions.
Ochenduszko SL; Krzemieniecki K
Anticancer Drugs; 2010 Sep; 21(8):737-48. PubMed ID: 20631611
[TBL] [Abstract][Full Text] [Related]
23. The epidermal growth factor receptor as a target for colorectal cancer therapy.
Lockhart AC; Berlin JD
Semin Oncol; 2005 Feb; 32(1):52-60. PubMed ID: 15726506
[TBL] [Abstract][Full Text] [Related]
24. Targeting IL-8 in colorectal cancer.
Ning Y; Lenz HJ
Expert Opin Ther Targets; 2012 May; 16(5):491-7. PubMed ID: 22494524
[TBL] [Abstract][Full Text] [Related]
25. Panitumumab: human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer.
Wu M; Rivkin A; Pham T
Clin Ther; 2008 Jan; 30(1):14-30. PubMed ID: 18343240
[TBL] [Abstract][Full Text] [Related]
26. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
Wadhawan A; Stephens R; Adams R
Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
28. [Current status and perspectives of biologics in the treatment of metastatic colorectal cancer].
Takiuchi H
Nihon Rinsho; 2010 Oct; 68(10):1866-70. PubMed ID: 20954331
[TBL] [Abstract][Full Text] [Related]
29. Targeted biotherapy in metastatic colorectal carcinoma: Current practice.
Cacheux W; Le Tourneau C; Baranger B; Mignot L; Mariani P
J Visc Surg; 2011 Feb; 148(1):12-8. PubMed ID: 21277276
[TBL] [Abstract][Full Text] [Related]
30. Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.
Marino D; Leone F; D'Avanzo F; Ribero D; Capussotti L; Aglietta M
Crit Rev Oncol Hematol; 2014 Dec; 92(3):218-26. PubMed ID: 24985058
[TBL] [Abstract][Full Text] [Related]
31. [Target Therapy in Unresectable or Metastatic Colorectal Cancer].
Kim JH; Park SJ
Korean J Gastroenterol; 2016 Dec; 68(6):303-311. PubMed ID: 28025473
[TBL] [Abstract][Full Text] [Related]
32. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
Venook AP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer.
Köhne CH; Lenz HJ
Oncologist; 2009 May; 14(5):478-88. PubMed ID: 19411318
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy of cetuximab in therapy of metastatic colorectal cancer: a system evaluation].
Hou SH; Liang XB; Bai WQ; Yang J; Yan D; Zhang X; Wang LC
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1387-90. PubMed ID: 19671328
[TBL] [Abstract][Full Text] [Related]
35. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
37. Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.
Vokes EE; Chu E
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 2):15-25. PubMed ID: 16736979
[TBL] [Abstract][Full Text] [Related]
38. Bevacizumab in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for first-line and maintenance treatment of metastatic colorectal cancer.
Grapsa D; Syrigos K; Saif MW
Expert Rev Anticancer Ther; 2015; 15(11):1267-81. PubMed ID: 26506906
[TBL] [Abstract][Full Text] [Related]
39. Panitumumab: a new frontier of target therapy for the treatment of metastatic colorectal cancer.
Addeo R; Caraglia M; Cerbone D; Frega N; Cimmino G; Abbruzzese A; Del Prete S
Expert Rev Anticancer Ther; 2010 Apr; 10(4):499-505. PubMed ID: 20397915
[TBL] [Abstract][Full Text] [Related]
40. [Does the sidedness determine the first line treatment of irresectable metastatic colorectal cancer?].
Kullmann T; Sipőcz I; Pintér T
Orv Hetil; 2017 Mar; 158(9):340-344. PubMed ID: 28245681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
